Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.6.0.2
Stock-Based Compensation (Tables)
 12 Months Ended
Nov. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Valuation Assumptions The fair value of the stock option grants below were estimated on the date of the grant using a Black-Scholes valuation model and the assumptions in the following table:

Assumptions:
Option Grant Date
Risk-free Interest Rate
Dividend Yield
Stock Volatility
Option Term (years)
January 5, 2015
1.57
%
—
%
37.74
%
10
April 9, 2015
1.40
%
—
%
37.79
%
10
December 1, 2015
1.19
%
—
%
39.39
%
5
June 22, 2016
1.20
%
—
%
36.43
%
10
June 22, 2016
1.20
%
—
%
36.43
%
5
October 5, 2016
1.26
%
—
%
36.29
%
5
Activity of Share-based Payment Award A summary of stock option activity for the Company is as follows:
 
Number of Options
Weighted-Average Exercise Price
Weighted-Average Remaining Term (years)
Aggregate Intrinsic Value
Outstanding at November 30, 2014
137,000
$3.40
5.70
—
Granted
185,000
$3.46
—
—
Exercised
—
—
—
—
Cancelled or Forfeited
218,000
$3.46
—
—
Outstanding at November 30, 2015
104,000
$3.41
7.91
—
Granted
519,000
$3.23
—
—
Exercised
—
—
—
—
Cancelled or Forfeited
59,000
$3.42
—
—
Outstanding at November 30, 2016
564,000
$3.25
5.83
—

Schedule of Stock Options, Future Amortization Expense A summary of the amortization expense of stock options outstanding as of November 30, 2016 is as follows:
For the years ended November 30,
2017
2018
2019
2020
2021
$107,677
$58,414
$58,414
$45,438
$24,345

Schedule of Shares Authorized by Exercise Price Range The following table summarizes information about currently outstanding and vested stock options at November 30, 2016:
 
 
Weighted-Average Remaining Term (years)
 
 
Number of Options Granted
Number of Option Shares Vested
Exercise Price
$3.03
14,000
9.85
—
$3.16
300,000
4.00
300,000
$3.18
10,000
8.35
2,000
$3.35
75,000
4.56
—
$3.35
130,000
9.56
—
$0.00
35,000
8.10
7,000
Total
564,000
 
309,000